Back to Results
First PageMeta Content



Research & Development Sumitomo Dainippon Pharma is actively investing its resources in new areas such as disease fields where no approved drugs exist and Regenerative Medicine & Cell Therapy as well as the focus therap
Add to Reading List

Document Date: 2015-09-03 20:48:20


Open Document

File Size: 172,25 KB

Share Result on Facebook